TABITHA DUGAL: Open Payments
NPI 1104270974 · WHITSETT, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$388 in 10 payments from 5 companies in 2025. Trend: 2023 $20 · 2024 $544 · 2025 $388
Food & beverage: $388
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $267 |
| AstraZeneca Pharmaceuticals LP | 2 | $40 |
| Otsuka America Pharmaceutical, Inc. | 1 | $34 |
| Corcept Therapeutics | 1 | $26 |
| Abbott Laboratories | 1 | $21 |
Products named: Wegovy, REXULTI, Korlym, FARXIGA, Ozempic, FREESTYLE LIBRE 3, AIRSUPRA.
Industry payments across NC — which companies pay providers there.
